Sales Reps: Adapting to Today’s Challenges

By July 17, 2024LTEN Focus On Training
Professional Development – By Keith Willis

Today’s life sciences landscape is markedly different


Pharmaceutical sales representatives have historically been the cornerstone of the industry, bridging the gap between manufacturers and healthcare professionals. Their traditional role has centered on direct, personal interactions with healthcare providers, educating them about the latest medications and their benefits and usage.

This relationship based approach has been crucial for building trust and credibility, facilitating drug adoption and ensuring that providers were well-informed about new treatments. Sales reps also play a vital role in gathering feedback on provider needs and patient outcomes, which has been invaluable for pharmaceutical companies.

Historical Context: The Traditional Role of Sales Reps

The role of pharmaceutical sales representatives is undergoing significant changes due to advances in technology, shifting market dynamics and evolving regulations.
These changes pose new challenges and necessitate adaptations to remain relevant. The industry has seen a shift in sales force sizes, with numbers peaking in 2005 but experiencing declines and slight rebounds thereafter.

Today, despite a similar number of sales positions versus 20 years ago, the landscape is markedly different with a shift toward specialized roles in fields like biotechnology, precision medicine and digital health. This evolution reflects the industry’s response to global healthcare challenges and the demand for more effective treatments.

According to a BioPharma Drive article, 85% of pharma launches will be smaller and a higher number of drugs will have a specialty designation. There are more teams  involved in other sales to include patient services, patient hubs, reimbursement teams and medical science liaisons (MSLs).

Sales reps must adapt to these changes by embracing new technologies, understanding the changing industry environment and a shift toward specialized therapeutic areas. This adaptation is crucial for navigating the landscape of the pharmaceutical industry.

Reps’ access to physicians has become more difficult with healthcare professional shortages, time spent with electronic medical record and health record systems and a complex healthcare system. Offices spend a tremendous amount of time helping patients gain access to products.

Technological Advancements and Market Dynamics

The pharmaceutical industry has transformed due to technological advancements and shifting market dynamics. Digital technology has changed the way products are marketed and information is disseminated. Digital marketing tools, social media platforms and e-detailing allow companies to reach a broader audience more efficiently than traditional face-to-face meetings.

While many companies have gone back to face-to-face meetings, many physicians prefer a blended marketing approach that includes virtual calls.  Market dynamics have shifted with increased competition from generic drug manufacturers, and biosimilars are beginning to impact the marketplace. These changes have pressured  pharmaceutical companies to refine their sales strategies, focusing more on cost-effectiveness and value-based selling.

Providers are looking for real-world data and evidence to not only validate clinical trials, but to understand the health economic value of products.

Key Sales Representative Strategies

As a pharmaceutical sales representative trying to stay relevant in a fast-evolving marketplace, it’s important to focus on continuous learning and professional development. Engage in training sessions and workshops to stay abreast of the latest pharmaceutical advancements and sales techniques. Embracing digital tools is also crucial, as is becoming proficient in using customer relationship management systems and virtual communication platforms, which are becoming integral in pharma sales.

Convey complex information clearly and tailor interactions to meet healthcare professionals’ needs by enhancing communication skills. Using artificial intelligence tools will move from experimental to a must-have skill across the industry.

Building a robust professional network through industry conferences and events can provide valuable insights and opportunities. Staying updated on market changes will ensure sales practices comply with the latest standards and laws.  Stay abreast by reading information about the disease state and changes in the industry.

Shifting your approach to be more patient-centric, focusing not just on the products but also on the outcomes and needs of patients, can strengthen relationships with healthcare providers.

Finally, develop resilience and adaptability to navigate market shifts and organizational changes. By incorporating these strategies, you can maintain a competitive edge and continue to succeed in the pharmaceutical industry.

Final Thoughts

Pharmaceutical sales representatives are the chameleons of the healthcare industry, adapting their colors to blend into the rapidly changing landscape around them.

Over the past 20 years, their role has transformed dramatically. Just as a chameleon that cannot change its colors might struggle to survive, sales representatives who fail  to adapt to new technologies, regulatory changes and market dynamics will find themselves fading into obsolescence.

Embracing continuous learning and a patient-centric approach is crucial for those looking to thrive in this vibrant and evolving field.


Keith Willis is president of Core Management Training. Email Keith at kwillis@coremanagementtraining.com or connect with him through linkedin.com/in/keithawillis.

 

LTEN

About LTEN

The Life Sciences Trainers & Educators Network (www.L-TEN.org) is the only global 501(c)(3) nonprofit organization specializing in meeting the needs of life sciences learning professionals. LTEN shares the knowledge of industry leaders, provides insight into new technologies, offers innovative solutions and communities of practice that grow careers and organizational capabilities. Founded in 1971, LTEN has grown to more than 3,200 individual members who work in pharmaceutical, biotech, medical device and diagnostic companies, and industry partners who support the life sciences training departments.

Leave a Reply